Smiths Group Plc · LSE:SMIN
Smiths — Shareholder Meeting (November 2020)
16 slides from Smiths's shareholder meeting presentation, Nov 16, 2020
Slide 1: Smiths Group plc Annual General Meeting
www.smiths.com SMITHS GROUP PLC ANNUAL GENERAL MEETING 16 NOVEMBER 2020
Slide 2: Disclaimer
DISCLAIMER This presentation contains certain statements that are forward-looking statements. They appear in a number of places throughout this presentation and include statements regarding the intentions, beliefs and/or current expectations of Smiths Group plc (the “Company”) and its subsidiaries (
Slide 3: Chairman of the meeting: Mark Seligman
Chairman of the meeting MARK SELIGMAN 3 SMITHS GROUP PLC | AGM 2020
Slide 4: Chairman's address
Chairman’s address SIR GEORGE BUCKLEY CHAIRMAN 4 SMITHS GROUP PLC | AGM 2020
Slide 5: Chief Executive's review
Chief Executive’s review ANDY REYNOLDS SMITH CHIEF EXECUTIVE 5 SMITHS GROUP PLC | AGM 2020
Slide 6: Q1 Trading Update
Q1 Trading Update A good 1st quarter trading performance showing strength and resilience Continuing Operations1 revenue down (2)% Smiths Medical2 revenue up 4% Continued strong cash generation Performance underpins the Group’s confidence in meeting FY market expectations 1 Continuing operations excl
Slide 7: FY2020 review - Leading now and in the future
FY2020 review - Leading now and in the future A robust FY2020 – strong operationally, financially and strategically Leading now – managing well through the uncertainty, executing the strategic restructuring programme and further portfolio upgrading Leading in the future – strengthened position for c
Slide 8: Putting our people and customers first
Putting our people and customers first Safety of our people at the centre of everything we do Smiths Excellence System supporting very strong business continuity throughout the pandemic Exceptional customer service and deliveries Supporting the fight against COVID-19 with Medical critical care produ
Slide 9: Executing the strategic restructuring programme
Executing the strategic restructuring programme Pulls together existing initiatives across the Group globally Further improving business efficiency and speed long term Accelerates progress to our 18-20% target margin range with 200bps margin improvement in FY22 Ensuring we are better positioned for
Slide 10: Smiths Medical
Smiths Medical Further progress in growth and margin improvement plan with third consecutive quarter of growth Significant agreement with U.S. government for syringe and needle production to support COVID-19 vaccine efforts New product launch program delivering results Separation was delayed during
Slide 11: Continued portfolio strengthening
Continued portfolio strengthening TRANSACTIONS Organic growth complemented by disciplined M&A 11 DISPOSALS c.£535m proceeds 10 ACQUISITIONS for c.£965m = 21 total value c.£1.5bn (FY16-FY20) Smiths Detection - PathSensors Smiths Medical – Smiths Interconnect – Reflex Access Scientific Photonics - Aug
Slide 12: Designed to outperform
Designed to outperform Resilient characteristics: Well positioned in long-term, attractive growth markets Technology differentiation A culture of innovation, operational excellence and great people Digitisation High proportion of Continued portfolio optimisation aftermarket services Sustainably comp
Slide 13: Poll vote resolutions
Poll vote resolutions 1. Adoption of Annual Report FY2020 12. Re-election of Andrew Reynolds Smith as a director 2. Approval of Directors’ Remuneration Report 13. Re-election of Noel Tata as a director 3. Declaration of a final dividend 14. Appointment of KPMG LLP as auditors 4. Election of Pam Chen
Slide 14: Questions & Answers
www.smiths.com QUESTIONS & ANSWERS
Slide 15: Proxy votes cast
Proxy votes cast 327 million proxy votes cast 86.6% of the issued share capital Continued strong support - full results will be available on the website 15 SMITHS GROUP PLC | AGM 2020
Slide 16: Making a safer, more efficient and better connected world
www.smiths.com MAKING A SAFER, MORE EFFICIENT AND BETTER CONNECTED WORLD